Zobrazeno 1 - 7
of 7
pro vyhledávání: '"L M Linares-González"'
Autor:
C Landa Solís, P Ostoa-Saloma, M Valdés-Flores, Eréndira Estrada-Villaseñor, L M Linares-González, A Meneses, J M Coutiño-Alcaraz, E A Delgado Cedillo, A Olivos Meza
Publikováno v:
American Journal of Cancer Research and Reviews. :13
Giant cell tumor of bone (GCTB) is a primary bone tumor, locally aggressive. For many, a GCTB is considered a tumor with an unpredictable behavior, particularly regarding recurrences, pulmonary implants, and the possibility of primary malignancy. In
Autor:
L M, Linares-González, G, Rico-Martínez, V M, Dominguez-Hernández, V, Araujo-Monsalvo, E A, Delgado-Cedillo, S R, León-Hernández
Publikováno v:
Acta ortopedica mexicana. 28(1)
Conservative surgery and reconstruction with an unconventional prosthesis are indicated for tumors of the humerus without neurovascular compromise, as they help preserve shoulder, elbow and hand function. The humerus is the third most frequent site o
Autor:
G, Rico-Martínez, L M, Linares-González, E A, Delgado-Cedillo, G, Espejo-Sánchez, L A, Cerrada-Moreno, M A, Clara-Altamirano
Publikováno v:
Acta ortopedica mexicana. 27(4)
Giant cell tumor (GCT) is an aggressive benign neoplasia that accounts for 5% of primary bone tumors and 20% of all benign bone tumors. It appears almost exclusively after skeletal maturation, between 20 and 40 years of age, and is predominant among
Autor:
G, Rico-Martínez, E A, Delgado-Cedillo, L M, Linares-González, H, Lindoro-Félix, S R, León-Hernández
Publikováno v:
Acta ortopedica mexicana. 27(5)
To assess the functional efficacy of the RIMAG unconventional hip prosthesis in cancer and non-cancer patients.Functional analysis of 38 patients with RIMAG arthroplasty, using the Musculoskeletal Tumor Society Scoring System and including the follow
Autor:
G, Espejo-Sánchez, G, Rico-Martínez, L M, Linares-González, E, Delgado-Cedillo, M A, Clara-Altamirano
Publikováno v:
Acta ortopedica mexicana. 26(4)
Chondrosarcoma is a malignant tumor of chondroid matrix-producing cells; based on its frequency, it is the second most common malignant bone tumor (10-20%) and responds poorly to chemo- and radiotherapy. It is infrequent in the pelvis. It has a rapid
Autor:
L M, Linares-González, Mario, Mercuri
Publikováno v:
Acta ortopedica mexicana. 25(4)
Autor:
G, Rico-Martínez, L M, Linares-González, E A, Delgado-Cedillo, E G, Estrada-Villaseñior, T E, Méndez-Vázquez
Publikováno v:
Acta ortopedica mexicana. 24(6)
Benign fibrous histiocytoma is a rare tumor with very stringent radiologic and histopathologic criteria. It accounts for approximately 1% of all the benign bone tumors. It may be located in both the soft tissues and bone. Its usual location is the sh